Price (delayed)
$5.61
Market cap
$428.51M
P/E Ratio
561
Dividend/share
N/A
EPS
$0.01
Enterprise value
$399.01M
ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create
There are no recent dividends present for CDXC.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.